Sanctuary Advisors LLC Has $22.84 Million Stock Position in Danaher Co. (NYSE:DHR)

Sanctuary Advisors LLC increased its stake in shares of Danaher Co. (NYSE:DHR - Free Report) by 3.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 82,155 shares of the conglomerate's stock after purchasing an additional 3,023 shares during the period. Sanctuary Advisors LLC's holdings in Danaher were worth $22,841,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Great Valley Advisor Group Inc. increased its position in shares of Danaher by 11.4% in the 2nd quarter. Great Valley Advisor Group Inc. now owns 1,585 shares of the conglomerate's stock valued at $396,000 after buying an additional 162 shares in the last quarter. ORG Partners LLC increased its holdings in shares of Danaher by 7,633.3% in the second quarter. ORG Partners LLC now owns 464 shares of the conglomerate's stock worth $114,000 after acquiring an additional 458 shares in the last quarter. Coronation Fund Managers Ltd. raised its position in shares of Danaher by 29.9% during the second quarter. Coronation Fund Managers Ltd. now owns 6,389 shares of the conglomerate's stock worth $1,596,000 after purchasing an additional 1,470 shares during the period. Blue Trust Inc. lifted its holdings in shares of Danaher by 53.9% during the 2nd quarter. Blue Trust Inc. now owns 8,672 shares of the conglomerate's stock valued at $2,166,000 after purchasing an additional 3,037 shares in the last quarter. Finally, Brookstone Capital Management grew its position in shares of Danaher by 23.3% in the 2nd quarter. Brookstone Capital Management now owns 10,328 shares of the conglomerate's stock valued at $2,595,000 after purchasing an additional 1,955 shares during the period. Institutional investors own 79.05% of the company's stock.

Danaher Stock Performance

NYSE:DHR traded down $0.46 during mid-day trading on Friday, hitting $234.04. The stock had a trading volume of 1,085,927 shares, compared to its average volume of 2,779,170. Danaher Co. has a twelve month low of $222.53 and a twelve month high of $281.70. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. The stock has a market cap of $169.04 billion, a price-to-earnings ratio of 44.75, a PEG ratio of 4.33 and a beta of 0.83. The company's 50 day simple moving average is $247.62 and its 200 day simple moving average is $257.62.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, beating analysts' consensus estimates of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business had revenue of $5.80 billion for the quarter, compared to analysts' expectations of $5.59 billion. During the same quarter in the prior year, the business earned $2.02 EPS. The firm's revenue for the quarter was up 3.1% on a year-over-year basis. On average, equities research analysts forecast that Danaher Co. will post 7.5 earnings per share for the current year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, December 27th will be issued a $0.27 dividend. The ex-dividend date is Friday, December 27th. This represents a $1.08 annualized dividend and a yield of 0.46%. Danaher's dividend payout ratio is currently 20.61%.

Analyst Ratings Changes

DHR has been the topic of several research analyst reports. TD Cowen raised their target price on shares of Danaher from $310.00 to $315.00 and gave the stock a "buy" rating in a report on Wednesday, October 23rd. UBS Group dropped their price objective on shares of Danaher from $309.00 to $305.00 and set a "buy" rating on the stock in a report on Wednesday, October 23rd. KeyCorp upped their target price on shares of Danaher from $290.00 to $310.00 and gave the stock an "overweight" rating in a research note on Wednesday, October 23rd. StockNews.com lowered Danaher from a "buy" rating to a "hold" rating in a report on Thursday, December 5th. Finally, Robert W. Baird decreased their price objective on Danaher from $278.00 to $277.00 and set an "outperform" rating for the company in a report on Wednesday, October 23rd. Five equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, Danaher presently has a consensus rating of "Moderate Buy" and an average target price of $287.95.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.